Presentation is loading. Please wait.

Presentation is loading. Please wait.

PI-Based HCV-1 Therapy: Reasons to Hold Off

Similar presentations


Presentation on theme: "PI-Based HCV-1 Therapy: Reasons to Hold Off"— Presentation transcript:

1 PI-Based HCV-1 Therapy: Reasons to Hold Off

2 SPRINT-2: Overall SVR Rates

3 ADVANCE: Overall SVR and Relapse Rates

4 RESPOND-2 SVR Rates According to Treatment Arm and Prior Response

5 REALIZE: SVR According to Previous Response

6 Telaprevir Adverse Events and Discontinuations

7 Boceprevir: Adverse Events and Discontinuations

8 HCV Drug Pipeline

9 SPRINT-2: Response Rates According to Race

10 SPRINT-2: SVR in Advanced Fibrosis/Cirrhosis

11 ADVANCE Response Rates According to Race/Cirrhosis

12 RESPOND-2 SVR in Advanced Fibrosis/Cirrhosis

13 REALIZE: SVR by Baseline Fibrosis Stage and Previous Response

14 Treatment for F3-F4?

15 Treatment decision

16 Thank you!


Download ppt "PI-Based HCV-1 Therapy: Reasons to Hold Off"

Similar presentations


Ads by Google